Ethosomes and lipid-coated chitosan nanocarriers for skin delivery of a chlorophyll derivative: A potential treatment of squamous cell carcinoma by photodynamic therapy.
Administration, Cutaneous
Animals
Carcinoma, Squamous Cell
Cell Line, Tumor
Chitosan
/ administration & dosage
Chlorophyllides
/ administration & dosage
Drug Carriers
/ administration & dosage
Female
Ferrous Compounds
/ administration & dosage
Humans
Lipids
/ administration & dosage
Male
Mice
Nanoparticles
/ administration & dosage
Photochemotherapy
Photosensitizing Agents
/ administration & dosage
Skin
/ metabolism
Skin Absorption
Skin Neoplasms
Spheroids, Cellular
/ drug effects
Chlorophyll derivatives
Nanocarriers
Photodynamic therapy
Skin cancer
Skin delivery
Journal
International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127
Informations de publication
Date de publication:
10 Sep 2019
10 Sep 2019
Historique:
received:
21
03
2019
revised:
01
07
2019
accepted:
14
07
2019
pubmed:
20
7
2019
medline:
24
1
2020
entrez:
20
7
2019
Statut:
ppublish
Résumé
Photodynamic therapy (PDT) is a localized treatment strategy used for skin cancers such as squamous cell carcinoma (SCC), the second most common form of skin cancer. PDT combines a photosensitizer, laser source and tissue oxygen. In this study, the selected photosensitizer, ferrous chlorophyllin (Fe-CHL) was loaded in ethosomes and lipid coated chitosan (PC/CHI) nanocarriers to enhance skin delivery of Fe-CHL for potential PDT of squamous carcinoma. The nanocarrier formulations were characterized and studied for their skin retention and penetration depth of Fe-CHL across mouse skin ex vivo using high performance liquid chromatography and confocal microscopy. Confocal microscope images of mouse skin showed deeper penetration of ethosomes down to the dermis when compared to PC/CHI that was confined to the epidermis, although they showed no significant difference in skin retention. Immunohistochemistry (IHC) staining with ki67 and TUNEL show maintained skin structure and no cytotoxic effects of the nanocarrier gel formulations before laser exposure to mouse skin. The nanocarriers were also studied for their PDT effect against human SCC monolayer and three-dimensional (3-D) spheroids. When compared to ethosomes, PC/CHI showed higher cytotoxicity in MTT assay and live confocal microscopy showed cell disintegration after laser exposure. For 3-D spheroids, PC/CHI also showed higher cytotoxicity using acid phosphatase assay and a decrease in spheroid size was observed using light microscopy. In conclusion, both types of nanocarriers can be used for their potential treatment of SCC using PDT depending on the tumour localization in the skin.
Identifiants
pubmed: 31323373
pii: S0378-5173(19)30572-1
doi: 10.1016/j.ijpharm.2019.118528
pii:
doi:
Substances chimiques
Chlorophyllides
0
Drug Carriers
0
Ferrous Compounds
0
Lipids
0
Photosensitizing Agents
0
Chitosan
9012-76-4
chlorophyllin
EEM82VOY7C
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
118528Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.